Nelson Van Denburg & Campbell Wealth Management Group LLC Invests $71,000 in Omega Healthcare Investors Inc (NYSE:OHI)

Share on StockTwits

Nelson Van Denburg & Campbell Wealth Management Group LLC purchased a new position in Omega Healthcare Investors Inc (NYSE:OHI) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,700 shares of the real estate investment trust’s stock, valued at approximately $71,000.

Several other large investors have also bought and sold shares of OHI. KBC Group NV increased its position in Omega Healthcare Investors by 22.1% during the second quarter. KBC Group NV now owns 20,511 shares of the real estate investment trust’s stock worth $754,000 after purchasing an additional 3,709 shares during the last quarter. Swiss National Bank increased its position in shares of Omega Healthcare Investors by 9.1% during the second quarter. Swiss National Bank now owns 399,058 shares of the real estate investment trust’s stock valued at $14,665,000 after acquiring an additional 33,300 shares during the last quarter. Wealthsource Partners LLC increased its position in shares of Omega Healthcare Investors by 4.9% during the second quarter. Wealthsource Partners LLC now owns 10,421 shares of the real estate investment trust’s stock valued at $383,000 after acquiring an additional 486 shares during the last quarter. Moors & Cabot Inc. increased its position in shares of Omega Healthcare Investors by 9.8% during the second quarter. Moors & Cabot Inc. now owns 7,315 shares of the real estate investment trust’s stock valued at $264,000 after acquiring an additional 653 shares during the last quarter. Finally, Trustcore Financial Services LLC increased its position in shares of Omega Healthcare Investors by 1.7% during the second quarter. Trustcore Financial Services LLC now owns 27,079 shares of the real estate investment trust’s stock valued at $995,000 after acquiring an additional 462 shares during the last quarter. 69.29% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have weighed in on the stock. Wells Fargo & Co lifted their price target on shares of Omega Healthcare Investors from $36.00 to $40.00 and gave the company a “market perform” rating in a research report on Friday, August 23rd. Raymond James lifted their price target on shares of Omega Healthcare Investors from $42.00 to $44.00 and gave the company a “strong-buy” rating in a research report on Thursday, September 12th. Zacks Investment Research cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research report on Thursday, September 12th. They set a “buy” rating and a $47.00 price target for the company. Seven equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. Omega Healthcare Investors presently has an average rating of “Hold” and an average target price of $40.04.

Shares of Omega Healthcare Investors stock opened at $42.42 on Friday. Omega Healthcare Investors Inc has a 52-week low of $31.83 and a 52-week high of $42.94. The company has a 50 day moving average of $41.26 and a 200 day moving average of $37.99. The company has a quick ratio of 2.78, a current ratio of 2.78 and a debt-to-equity ratio of 1.17. The company has a market capitalization of $9.22 billion, a P/E ratio of 13.95, a P/E/G ratio of 5.60 and a beta of 0.34.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.39). Omega Healthcare Investors had a return on equity of 6.79% and a net margin of 29.38%. The firm had revenue of $191.81 million during the quarter, compared to analysts’ expectations of $190.46 million. During the same quarter in the prior year, the firm earned $0.75 EPS. The firm’s revenue was down .5% compared to the same quarter last year. As a group, research analysts anticipate that Omega Healthcare Investors Inc will post 2.96 earnings per share for the current fiscal year.

In other news, CFO Robert O. Stephenson sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $39.00, for a total transaction of $390,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Michael Ritz sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, September 25th. The stock was sold at an average price of $42.00, for a total transaction of $105,000.00. Following the sale, the chief accounting officer now owns 5,485 shares of the company’s stock, valued at approximately $230,370. The disclosure for this sale can be found here. Insiders sold 45,500 shares of company stock valued at $1,822,300 in the last quarter. 1.16% of the stock is owned by insiders.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Featured Story: Understanding Specialty Certificates of Deposit

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.